Research Article
BibTex RIS Cite

continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome

Year 1992, Volume: 5 Issue: 2, 63 - 66, 01.04.1992
https://izlik.org/JA74FK86BS

Abstract

Acute tumor lysis syndrome and associated renal failure are frequently seen in children with B cell leukemia and lymphoma. In patients resistant to conservative management, renal replacement therapy is required. Continuous arteriovenous hémodiafiltration (CAVHD) and continuous arteriovenous hemofiltration (CAVH) were used successfully in the treatment of tumor lysis syndrome and renal failure preceding chemotherapy in a child with B cell leukemia. The advantages of the methods are discussed.

References

  • Cadman EC. Lundberg WB, Bertlno JR. Hyperphos phatemla and hypocalcemia accompanying rapid cell lysis In a patient with Burkitt's lymphoma and Burkitt cell leukemia. Am J Med 1977; 62:283-290.

Year 1992, Volume: 5 Issue: 2, 63 - 66, 01.04.1992
https://izlik.org/JA74FK86BS

Abstract

References

  • Cadman EC. Lundberg WB, Bertlno JR. Hyperphos phatemla and hypocalcemia accompanying rapid cell lysis In a patient with Burkitt's lymphoma and Burkitt cell leukemia. Am J Med 1977; 62:283-290.
There are 1 citations in total.

Details

Subjects Clinical Sciences
Journal Section Research Article
Authors

L. Sağlamer This is me

H. Öz This is me

S. Çalışkan This is me

A. Ekinci This is me

L. Uıukutlu This is me

L. Sever This is me

İ. Yıldız This is me

B. Aykaç This is me

Publication Date April 1, 1992
IZ https://izlik.org/JA74FK86BS
Published in Issue Year 1992 Volume: 5 Issue: 2

Cite

APA Sağlamer, L., Öz, H., Çalışkan, S., Ekinci, A., Uıukutlu, L., Sever, L., Yıldız, İ., & Aykaç, B. (1992). continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome. Marmara Medical Journal, 5(2), 63-66. https://izlik.org/JA74FK86BS
AMA 1.Sağlamer L, Öz H, Çalışkan S, et al. continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome. Marmara Med J. 1992;5(2):63-66. https://izlik.org/JA74FK86BS
Chicago Sağlamer, L., H. Öz, S. Çalışkan, et al. 1992. “Continuous Arteriovenous Hemodiafiltration and Hemofiltration in the Treatment of Tumor Lysis Syndrome”. Marmara Medical Journal 5 (2): 63-66. https://izlik.org/JA74FK86BS.
EndNote Sağlamer L, Öz H, Çalışkan S, Ekinci A, Uıukutlu L, Sever L, Yıldız İ, Aykaç B (April 1, 1992) continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome. Marmara Medical Journal 5 2 63–66.
IEEE [1]L. Sağlamer et al., “continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome”, Marmara Med J, vol. 5, no. 2, pp. 63–66, Apr. 1992, [Online]. Available: https://izlik.org/JA74FK86BS
ISNAD Sağlamer, L. - Öz, H. - Çalışkan, S. - Ekinci, A. - Uıukutlu, L. - Sever, L. - Yıldız, İ. - Aykaç, B. “Continuous Arteriovenous Hemodiafiltration and Hemofiltration in the Treatment of Tumor Lysis Syndrome”. Marmara Medical Journal 5/2 (April 1, 1992): 63-66. https://izlik.org/JA74FK86BS.
JAMA 1.Sağlamer L, Öz H, Çalışkan S, Ekinci A, Uıukutlu L, Sever L, Yıldız İ, Aykaç B. continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome. Marmara Med J. 1992;5:63–66.
MLA Sağlamer, L., et al. “Continuous Arteriovenous Hemodiafiltration and Hemofiltration in the Treatment of Tumor Lysis Syndrome”. Marmara Medical Journal, vol. 5, no. 2, Apr. 1992, pp. 63-66, https://izlik.org/JA74FK86BS.
Vancouver 1.Sağlamer L, Öz H, Çalışkan S, Ekinci A, Uıukutlu L, Sever L, et al. continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome. Marmara Med J [Internet]. 1992 Apr. 1;5(2):63-6. Available from: https://izlik.org/JA74FK86BS